Page last updated: 2024-09-02

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and triiodothyronine

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with triiodothyronine in 2 studies

Compound Research Comparison

Studies
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Trials
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Recent Studies (post-2010)
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Studies
(triiodothyronine)
Trials
(triiodothyronine)
Recent Studies (post-2010) (triiodothyronine)
1387226,2478613,473

Protein Interaction Comparison

ProteinTaxonomyl-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50)triiodothyronine (IC50)
Thyroid hormone receptor alphaHomo sapiens (human)0.0006
Thyroid hormone receptor betaHomo sapiens (human)0.0006
Proliferating cell nuclear antigenHomo sapiens (human)3.6
Thyroid hormone receptor betaRattus norvegicus (Norway rat)0.0031
Adenosine receptor A1Homo sapiens (human)0.4109

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eckland, DJ; Guiloff, RJ; Lightman, SL; Modarres-Sadeghi, H1
Eckland, DJ; Lightman, SL1

Trials

1 trial(s) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and triiodothyronine

ArticleYear
The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man.
    European journal of clinical investigation, 1988, Volume: 18, Issue:4

    Topics: Adult; Central Nervous System; Humans; Male; Prolactin; Pyrrolidonecarboxylic Acid; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1988

Other Studies

1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and triiodothyronine

ArticleYear
The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
    Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:9

    Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Motor Neurons; Neuromuscular Diseases; Prolactin; Pyrrolidonecarboxylic Acid; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1990